About this trial
This study aims to assess the impact of occlusal reduction on post-operative pain after single-visit root canal treatment in patients with necrotic pulps or previously initiated (accessed).
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Systemically healthy subjects (ASA I&II) between the age of 18 and 70 years
Patients diagnosed with necrotic pulp or previously initiated (accessed).
Posterior maxillary or mandibular molar tooth.
Presence of an opposing tooth (or teeth) with normal occlusal contact with the opposing tooth (or teeth).
Disqualifiers
Pregnant females.
Patients with significant medical conditions (ASA III & IV).
Reported bruxism or clenching.
Took analgesics\antibiotics or other drugs that might alter their pain during the last 12 hours preoperatively.
Trial design
Parallel
Treatments tested in this trial
Occlusal Reduction
Procedure/Surgerypatients will be allocated to either undergo occlusal reduction (Intervention group) where all occlusal contacts on the functional and non-functional cusps as well as on the marginal ridges will be reduced using a diamond bur, or not undergo occlusal reduction (Control group) where all occlusal contacts will remain intact. The presence or absence of contact will be confirmed using articulating paper where occlusal surfaces will be dried and articulating paper will be held between the teeth with the mandible guided to the centric position. Intact occlusion will be assessed by examining the marks on the teeth. A high-speed handpiece with copious coolant will be used to remove occlusal contacts (Intervention group) or just moved above the surface of the tooth without contacting the occlusal surface (Control group) to facilitate patient blinding.
Treatment groups
Trial outcomes
Primary outcomes
impact of occlusal reduction on post-operative pain after single-visit root canal treatment by using the visual analog scale (VAS).
to assess the impact of occlusal reduction on post-operative pain after single-visit root canal treatment in patients with necrotic pulps or previously initiated (accessed) by using visual analog scale (VAS) at 6, 24, 48 hours, and 1 week following the treatment. The VAS consists of a 10-cm line anchored by two extremes "No pain" and "pain as bad as could be". The patients were asked to choose the mark that represented their level of pain. Pain level was assigned to one of four categorical groups: None (0); Mild (1-3); Moderate (4- 6); Severe (7-10). The scale was explained visually, verbally and numerically to facilitate its use by the participants. This will be done by calling the patients by phone to record the degree of pain at these intervals as explained in the study description.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.